Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-2, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis
April 03, 2023 07:00 ET | FibroGen, Inc.
- 372 IPF Patients Enrolled -- Topline Data Anticipated Mid-2024 - SAN FRANCISCO, April 03, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the completion of patient...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen to Report Fourth Quarter and Full Year 2022 Financial Results
February 17, 2023 07:00 ET | FibroGen, Inc.
SAN FRANCISCO, Feb. 17, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its fourth quarter and full year 2022 financial results on Monday, February 27 after the market close....
AspireHR Recruiting
Identify, Attract, and Hire Top Talent Faster with AspireHR Recruiting
September 13, 2022 13:30 ET | AspireHR
Las Vegas, NV, Sept. 13, 2022 (GLOBE NEWSWIRE) -- AspireHR, an SAP Gold Partner and one of the largest North American HCM implementation, software, and managed services firms, announced its launch...
GR8-Wordmark-Black-01.png
Indeed and GR8 People partner to drive passive sourcing with access to over 200 million resumes
June 20, 2022 07:00 ET | GR8 People
PHILADELPHIA, June 20, 2022 (GLOBE NEWSWIRE) -- GR8 People, the leading talent acquisition platform to source, attract, engage and hire every workforce type in one seamless experience, announced a...
JD Regular Logo.PNG
JobDiva Announces New Integration with CloudCall
June 08, 2022 15:37 ET | JobDiva
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- JobDiva is proud to announce a new integration with CloudCall, a computer telephony integration (CTI) designed for CRM. This system will enable recruiters...
Atyr_Logo.png
aTyr Pharma Presents Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference
May 17, 2022 08:00 ET | aTyr Pharma, Inc.
Results from Phase 1b/2a study of efzofitimod in pulmonary sarcoidosis patients demonstrate dose-dependent improvements in key physiologic and quality of life measures in context of a steroid taper. ...
ClearStar Appoints Three New C-Suite Executives
ClearStar Names Three New C-Suite Executives as Company Eyes Unprecedented Growth
April 26, 2022 17:20 ET | ClearStar
ALPHARETTA, Ga., April 26, 2022 (GLOBE NEWSWIRE) -- ClearStar, Inc. ("ClearStar"), a leading HR-technology company specializing in background and medical screening services announces three new...
Atyr_Logo.png
aTyr Pharma to Present Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference
April 01, 2022 08:00 ET | aTyr Pharma, Inc.
Results from Phase 1b/2a study of efzofitimod in pulmonary sarcoidosis patients demonstrate safety and dose dependent trends of improvement compared to placebo for key efficacy endpoints. Efzofitimod...
Fountain_Logo_Blue.png
Fountain Launches Innovative Suite of Solutions for Sourcing Applicants to Drive Growth of Industry-leading High Volume Hiring Platform
March 16, 2022 09:00 ET | Fountain
SAN FRANCISCO, March 16, 2022 (GLOBE NEWSWIRE) -- Fountain, the world's leading applicant tracking system (ATS) for high volume hiring, today announced Fountain Source – a full suite of sourcing...
homepagetoplogosocrates-178x38-100.jpg
Socrates.ai and Jobma Announce Alliance to Optimize the Candidate to Employee Journey
March 10, 2022 12:00 ET | Socrates.ai
WOODSIDE, Calif. and MOUNTAIN VIEW, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Socrates.ai, a leading employee experience platform, and Jobma, a digital interviewing company that simplifies hiring,...